急性脑梗死交感神经皮肤反应检测与临床相关性研究

目的 探讨急性脑梗死患者交感神经皮肤反应(SSR)变化特点及与病情严重程度之间的相关性.方法 将94例急性脑梗死患者分为3组:皮质-皮质下、基底节-丘脑及脑桥组,所有患者均于入院当天进行日常生活能力和临床神经功能缺损(MESSS)评分,并根据瘫痪程度进行分级.于入院3d内行SSR检查,并对检查结果进行分析.结果 (1)急性脑梗死SSR异常率为40.4%,异常率以基底节-丘脑组最高、皮质-皮质下组次之,脑桥组最低;(2)SSR异常率高及波形缺失者,患者肢体瘫痪、临床神经功能缺损程度重、日常生活能力低.SSR异常及波形缺失与瘫痪程度、MESSS评分呈正相关,与BI评分呈负相关.而潜伏期延长、波幅低与瘫痪程度、MESSS及BI评分无关.结论 (1)急性脑梗死后可出现交感神经反射活动的抑制.SSR检测技术可以定量评价急性脑梗死后交感神经的功能状态.(2)SSR异常及波形缺失反映了运动功能受损情况.     

脑梗死患者交感神经皮肤反应分析

交感神经皮肤反应（sympathetic skin response,SSR）是由内源或外源性刺激所诱发的皮肤 瞬时电位变化,属于脑和脊髓参与的交感催汗运动。本文主要概述近年来SSR在脑梗死患者中应用 价值,阐述其对脑梗死患者自主神经功能紊乱的临床诊断作用,与脑梗死患者运动功能的相关性, 以及SSR在推断交感神经可能的中枢传导通路中的价值。     

多发性硬化交感神经皮肤反应的研究

对３８例多发性硬化（ＭＳ）患者和４１例正常人的交感神经皮肤反应（ＳＳＲ）与多方式诱发电位进行研究。结果：３８例确诊和近似确诊的ＭＳ患者ＳＳＲ异常率（８１．６％）比异常的诱发电位更为常见。在伴有自主神经症状的２１例ＭＳ患者中１９例ＳＳＲ异常（９０．５％），１７例无自主神经症状的ＭＳ患者中１２例ＳＳＲ异常（７０．６％）。提示：ＳＳＲ能客观有效地反映自主神经功能状态，检出ＭＳ的亚临床异常。将ＳＳＲ与多方式诱发电位联合评估ＭＳ中枢神经系统损害，具有更高的敏感性，有助于ＭＳ的早期诊断。     

83例正常人交感神经皮肤反应分析

目的 正常人的交感神经皮肤反应（ＳＳＲ）进行研究。方法 对８３例正常人用声、电刺激，双侧手掌、脚掌记录。对刺激方式、部位、年龄、性别、皮肤温度和身高诸因素进行分析，观察ＳＳＲ的变化特征和影响因素。结果 ①ＳＳＲ双侧对称，四肢同时发生；②潜伏期稳定，但波幅变异较大，重复刺激易产生习惯性；③几乎不受刺激方式和部位的影响；④皮肤温度３１℃时，波幅显著降低（Ｐ〈０．０１），３２－３４℃时，波幅有随温度增高     

帕金森病交感神经皮肤反应的临床研究

目的 探讨交感神经皮肤反应(SSR)对帕金森病自主神经功能障碍的诊断价值.方法 对解放军第一○二医院神经内科自2006年7月至2008年8月门诊或住院的47例帕金森病患者及与之相匹配的20例健康人进行SSR检测,并对其中有自主神经功能障碍患者与无自主神经功能障碍患者的结果进行对比分析. 结果帕金森病患者与健康人相比,上肢潜伏期明显延长(1.55±0.18 vs 1.42±0.29),波幅明显降低(1.87±0.26 vs 2.56±1.47);下肢潜伏期明显延长(2.13±0.16vs 2.04±0.27),波幅明显降低(0.49±0.21 vs 0.76±0.39),差异均有统计学意义(P<0.05).有自主神经功能障碍患者与无自主神经功能障碍患者相比,上肢潜伏期明显延长(1.56 ± 0.17 vs 1.53 ± 0.15),波幅明显降低(1.75±0.21 vs 1.89±0.33);下肢潜伏期明显延长(2.17 ± 0.18 vs 2.08±0.24),波幅明显降低(0.46±0.20 vs 0.51±0.17),差异均有统计学意义(P<0.05). 结论 SSR检测结果与患者临床表现相一致,其对帕金森病患者的自主神经功能障碍有诊断价值.     

抑郁症患者的交感神经皮肤反应探讨

目的探讨交感神经皮肤反应(SSR)对抑郁症患者的临床价值。方法对45例抑郁症患者治疗前后和43例正常健康者分别进行SSR测定和汉密尔顿抑郁量表(HAMD)评定,并加以比较。结果抑郁症组治疗前SSR测定的异常率为84.4%(38/45),而治疗后异常率为13.3%(6/45)。治疗前SSR测定波潜伏期及波幅值较治疗后及对照组分别延长和降低,差异有统计学意义(P<0.01);治疗后抑郁症组HAMD评定分值较治疗前降低,差异有统计学意义(P<0.01)。相关分析结果表明,抑郁症患者SSR波潜伏期与HAMD分值呈显著正相关(P<0.01),其波幅与HAMD分值呈显著负相关(P<0.01)。结论交感神经皮肤反应测定可作为判定抑郁症患者自主神经功能的参考指标应用于临床。     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

帕金森病交感神经皮肤反应的临床研究

Objective To assess the value of detecting sympathetic skin response (SSR) in the diagnosis of autonomic dysfunction in patients with Parkinson disease (PD). Methods SSR measurement was performed in 47 PD patients and 20 healthy control subjects and the results were compared. The SSR was also comparatively analyzed between patients with and those without autonomic dysfimction. Results Compared with the healthy controls, the PD patients showed significantly lowered mean amplitude (2.56±1.47 vs 1.87±0.26, P<0.05) and prolonged latency (1.42±0.29 vs 1.55± 0.18, P<0.05) of the SSR in the upper limbs, with also lowered mean amplitude (0.76±0.39 vs 0.49±0.21, P<0.05) and prolonged latency (2.04±0.27 vs 2.13±0.16, P<0.05) in the lower limbs. Compared with the PD patients without autonomic dysfunction, those having autonomic dysfunction showed significantly lowered mean amplitude (1.89±0.33 vs 1.75±0.21, P<0.05) and prolonged latency (1.53±0.15 vs 1.56±0.17, P<0.05) of SSR in the upper limbs and lowered mean amplitude (0.51±0.17 vs 0.46±0.20,P<0.05) and prolonged latency (2.08±0.24 vs 2.17±0.18, P<0.05) in the lower limbs. Conclusion The results of SSR measurements are consistent with the clinical manifestations of the PD patients. SSR can be of value in the diagnosis of autonomic nerve dysfunction in PD.     

慢性紧张型头痛患者的抑郁和交感神经皮肤反应相关性的研究

目的探讨慢性紧张型头痛(CTTH)患者抑郁和交感神经皮肤反应(SSR)相关性。方法选取神经内科就诊、符合入组的CTTH患者54例,对照组为同期健康体检者40例,两组均行汉密顿抑郁量表(HAMD)和SSR检测。结果 CTTH患者轻度抑郁(HAMD8¹7分)26例,占48.15%;中、重度抑郁(HAMD>17分)10例,占18.52%。与对照组比较,轻度和中、重度抑郁患者SSR潜伏期均延长(p<0.01),而波幅均降低(p<0.01);无抑郁的CTTH患者SSR潜伏期亦显著长于对照组(p<0.05),而波幅显著低于对照组(p<0.05);中、重度抑郁患者较轻度抑郁患者SSR潜伏期延长(p<0.01),波幅降低(p<0.01)。结论 CTTH患者抑郁发生率高,CTTH患者存在皮肤交感神经兴奋性减低,伴发抑郁重者变化更为明显,SSR检测为CTTH的诊断和治疗可提供一定的参考价值。     

交感神经皮肤反应在帕金森病中的应用

目的探讨交感神经皮肤反应(SSR)在帕金森病(PD)患者自主神经损害中的评价作用。方法选用36例PD患者和30例健康对照者作为研究对象,行SSR检测,并对患者进行SCOPA-AUT评分及H-Y分级,评价SSR与PD自主神经损害的相关性。结果 PD患者SSR总异常率61.1%;H-Y评分0~1.5分者,SSR异常率为35.7%,H-Y评分2.0分者,SSR异常率77.3%;伴随自主神经症状的PD患者中(PD-AS),SSR异常率85.7%;不伴随自主神经症状者(PD-NAS),SSR异常率26.7%。结论 SSR可客观评价PD患者自主神经功能障碍,并检测PD自主神经的亚临床损害,且随患者运动症状加重,SSR异常越明显。     

T2DM患者交感神经皮肤反应特征分析

目的探讨2型糖尿病(T2DM)患者的交感神经皮肤反应(SSR)改变特征.方法测定88例T2DM患者的上、下肢体的SSR改变特征;并分析与病程、糖基化血红蛋白(以下简称HbA1C)的关系.选正常人50例作为对照组.结果 T2DM患者的上、下肢SSR的异常率分别为68.5%、58.5%,明显高于正常对照组(P《0.05) ,进一步发现,病程越长,HbAIC水平越高,SSR异常率越高.结论 T2DM患者存在着广泛的植物神经神经病变,SSR技术有助于诊断.     

颈交感神经节阻滞治疗偏头痛及其对交感神经皮肤反应的影响

目的探讨颈交感神经节阻滞治疗偏头痛的疗效及其对交感神经皮肤反应的影响。方法颈交感神经节阻滞受用颈6横突法，每日1次，两侧交替阻滞，共7次；应用神经电生理测定36例偏头痛患者治疗前后和30例健康人交感神经皮肤反应（SSR）。结果偏头痛患者经颈交感神经节阻滞后头痛次数减少、头痛时间缩短、程度减轻，与治疗前比较有显著性差异（P〈0．01）。偏头痛患者交感神经皮肤反应的潜伏期均明显长于对照组（P〈0．01），而波幅显著低于对照组（P〈0．01）；颈交感神经节阻滞后偏头痛患者交感神经皮肤反应恢复正常。结论颈交感神经节阻滞治疗偏头痛具有良好的疗效，并能改善偏头痛患者的自主神经功能（ANS）。     

巴金森病与多系统萎缩患者的交感神经皮肤反应研究

目的：研究原发性巴金森病（ＩＰＤ）与多系统萎缩（ＭＳＡ）交感神经皮肤反应（ＳＳＲ）,以搪塞它们自主神经功能障碍的差异。方法：对３１例ＩＰＤ、１７例ＭＳＡ和８３位正常人的ＳＳＲ结果比较,分析ＰＤ组和ＭＳＡ组ＳＳＲ异常特征和与病程、自主神经症状的相关性。结果：ＭＳＡ组ＳＳＲ异常率（７６％）显著高于ＩＰＤ组（４５％）,以双侧异常多见。３年内病程的ＳＳＲ异常率为７３％,并与自主神经症状相关。ＩＰＤ组ＳＳＲ